BNTC
BNTC
NASDAQ · Biotechnology

Benitec Biopharma Inc

$11.95
-0.10 (-0.83%)
As of May 9, 1:51 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +124.9% upside
Low Target $21.20
Average Target $26.87
High Target $38.04
Current Price $11.95
Current
$11.95
Target
$26.87
$21.20 $26.87 avg $38.04
Scenario Analysis
Bear Case
$21.20
77.4%
Low target
Base Case
$26.87
+124.9%
Avg target
Bull Case
$38.04
+218.3%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$17.15
-30.3% from high
52-Week Low
$9.85
+21.3% from low
Target vs 52W High
$26.87
+56.7% vs high
Next Earnings Report
May 12, 2026
1d
tomorrow
EPS Est: $-0.28
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%